Literature DB >> 8155325

Potassium channel inactivation peptide blocks cyclic nucleotide-gated channels by binding to the conserved pore domain.

R H Kramer1, E Goulding, S A Siegelbaum.   

Abstract

Cyclic nucleotide-gated (CNG) channels in photoreceptors and olfactory neurons are activated by intracellular ligands (cAMP and cGMP) rather than voltage. Surprisingly, these channels share amino acid sequence homology with voltage-gated channels. Here we show that the distinct gating mechanisms exhibited by CNG and voltage-gated channels share features that reflect this structural homology. Thus, a 20 amino acid peptide ("ball peptide") derived from the Shaker-type K+ channel and responsible for its rapid inactivation also blocks CNG channels. Moreover, the peptide selectively blocks open CNG channels and prevents channel closure, showing that CNG channel activation, like activation of voltage-dependent K+ channels, involves the opening of a gate located on the intracellular side of the peptide-binding site. Amino acid substitutions in the peptide cause similar changes in blocking affinity of CNG and K+ channels, suggesting a conserved binding site. Using a chimeric retinal/olfactory channel, we show that the difference in the peptide affinity of the two CNG channels is due to a difference in the amino acid sequence of the conserved pore-forming region, demonstrating that this domain forms part of the peptide receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8155325     DOI: 10.1016/0896-6273(94)90220-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  17 in total

Review 1.  Structural basis for the selective permeability of channels made of communicating junction proteins.

Authors:  Jose F Ek-Vitorin; Janis M Burt
Journal:  Biochim Biophys Acta       Date:  2012-02-10

2.  Interaction between ion channel-inactivating peptides and anionic phospholipid vesicles as model targets.

Authors:  J A Encinar; A M Fernandez; F Gavilanes; J P Albar; J A Ferragut; J M Gonzalez-Ros
Journal:  Biophys J       Date:  1996-09       Impact factor: 4.033

3.  Inactivating peptide of the Shaker B potassium channel: conformational preferences inferred from studies on simple model systems.

Authors:  J A Encinar; A M Fernández; E Gil-Martín; F Gavilanes; J P Albar; J A Ferragut; J M González-Ros
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

4.  The equine periodic paralysis Na+ channel mutation alters molecular transitions between the open and inactivated states.

Authors:  W J Hanna; R G Tsushima; R Sah; L J McCutcheon; E Marban; P H Backx
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

5.  Voltage-dependent gating characteristics of the K+ channel KAT1 depend on the N and C termini.

Authors:  I Marten; T Hoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  Intramolecular interactions mediate pH regulation of connexin43 channels.

Authors:  G E Morley; S M Taffet; M Delmar
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

7.  Effects of ultraviolet modification on the gating energetics of cyclic nucleotide-gated channels.

Authors:  T R Middendorf; R W Aldrich
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

8.  Access of quaternary ammonium blockers to the internal pore of cyclic nucleotide-gated channels: implications for the location of the gate.

Authors:  Jorge E Contreras; Miguel Holmgren
Journal:  J Gen Physiol       Date:  2006-04-10       Impact factor: 4.086

9.  Effects of cysteine modification on the activity of the cGMP-gated channel from retinal rods.

Authors:  V Serre; M Ildefonse; N Bennett
Journal:  J Membr Biol       Date:  1995-07       Impact factor: 1.843

10.  Simultaneous binding of basic peptides at intracellular sites on a large conductance Ca2+-activated K+ channel. Equilibrium and kinetic basis of negatively coupled ligand interactions.

Authors:  I Favre; E Moczydlowski
Journal:  J Gen Physiol       Date:  1999-02       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.